RenovoRx Receives CE Mark for RenovoCath™
RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system, today announced that the company achieved the CE Mark for commercial sale of the RenovoCath™. The catheter will offer EU physicians a new tool for targeted delivery of fluids. “Achieving the CE Mark for the […]
RenovoRx Receives CE Mark for RenovoCath™
RenovoRx today announced that the company achieved the CE Mark for commercial sale of the RenovoCath™. The catheter will offer EU physicians a new tool for targeted delivery of fluids.